Nuvation Bio Inc.NUVBNYSE
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-130.57M
↓ 115% below average
Average (6y)
$-60.85M
Historical baseline
Range
High:$-616000.00
Low:$-130.57M
CAGR
+144.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-130.57M | -91.8% |
| 2023 | $-68.07M | +29.4% |
| 2022 | $-96.48M | -40.9% |
| 2021 | $-68.47M | -86.7% |
| 2020 | $-36.67M | -46.2% |
| 2019 | $-25.09M | -3973.2% |
| 2018 | $-616000.00 | - |